PCK1 and metabolic dysfunction-associated steatotic liver disease: This raises the intriguing possibility that downregulation of Pck1 in female Adra1bLKO mice could lead to liver alterations in the long term, suggesting a potential protective role of liver ADRA1B in the progression toward MASLD.